Skip to main content

Alzheimer's Disease, Dementia & Cognitive Disorders

People with dementia have double the risk of contracting COVID-19, and have higher hospitalization and mortality rates when they do get the virus, compared with those without dementia, according to a published study.
Three major molecular subtypes of Alzheimer's disease (AD) identified by researchers could be biomarkers that lead to earlier diagnosis and intervention.
The protein transthyretin (TTR) may play a role in the development of new treatments for Alzheimer’s disease by preventing the formation of amyloid beta clumps, according to a study.
Donanemab, an investigational antibody, showed significant slowing of decline in a composite measure of cognition and daily function in patients with early symptomatic Alzheimer's disease, according to a phase 2 trial by Eli Lilly and Company.
Patients with early Alzheimer’s disease homozygous for the ε4 allele of apolipoprotein E gene (APOE4/4) had accelerated hippocampal atrophy and cortical thinning that correlated with cognitive decline, according to a published study.
Consuming more food and drink with the antioxidant flavonol is associated with a smaller chance of developing Alzheimer’s dementia years later, researchers reported in Neurology.
Back to Top